Phase 1 Hepatic Impairment (HI) Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

A Study to Evaluate EDG-7500 in Adults With Hepatic Impairment

Hepatic Impairment (HI)

Edgewise Therapeutics, Inc.32 enrolled2 locationsNCT07324616

Recruiting

Phase 1

A Study of Nemtabrutinib in Participants With Moderate Hepatic Impairment (MK-1026-015)

Hepatic Impairment (HI)

Merck Sharp & Dohme LLC32 enrolled3 locationsNCT06442436